Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Deckert

Showing results (121-130 of 150) with videos related to

Pageof 15
Sort By:
Neurology|January 3, 2001
Limbic encephalitis not associated with neoplasm as a cause of temporal lobe epilepsyC G Bien, A Schulze-Bonhage, M Deckert, et al.
British Journal of Cancer|March 20, 2003
A33scFv-cytosine deaminase: a recombinant protein construct for antibody-directed enzyme-prodrug therapyP M Deckert, C Renner, L S Cohen, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|January 1, 1993
Expansion of peripheral blood natural killer cells correlates with clinical outcome in cancer patients receiving recombinant subcutaneous interleukin-2 and interferon-alpha-2J Atzpodien, H Kirchner, A Körfer, et al.
Seminars in Oncology|December 1, 1993
European studies of interleukin-2 in metastatic renal cell carcinomaJ Atzpodien, H Kirchner, E L Hänninen, et al.
Oncology|July 1, 1994
Immunocytochemical detection of P-glycoprotein: initial expression correlates with survival in renal cell carcinoma patientsS Duensing, I Dallmann, J Grosse, et al.
Journal of Receptor and Signal Transduction Research|January 15, 2005
From transcription profile to expression: the signaling repertoire of the SK-N-MC neuroepithelioma cell-lineJürgen E Bader, Cornelia M Deckert, Norman Koglin, et al.
Oncogene|April 4, 2007
Id3 is a novel regulator of p27kip1 mRNA in early G1 phase and is required for cell-cycle progressionA-A Chassot, L Turchi, T Virolle, et al.
Cancer Biotherapy|January 1, 1994
In vivo time and dose dependency of interleukin-6 secretion in response to low-dose subcutaneous recombinant interleukin-2M Meffert, E L Hanninen, T Menzel, et al.
The American Journal of Pathology|December 14, 1999
Primary central nervous system lymphomas are derived from germinal-center B cells and show a preferential usage of the V4-34 gene segmentM Montesinos-Rongen, R Küppers, D Schlüter, et al.
Neuropathology and Applied Neurobiology|March 5, 2013
Differential effects of CXCR4-CXCL12- and CXCR7-CXCL12-mediated immune reactions on murine P0106-125 -induced experimental autoimmune neuritisA Brunn, O Utermöhlen, M Mihelcic, et al.
Pageof 15

Showing results (121-130 of 150) with videos related to

Sort By:
Pageof 15
Neurology|January 3, 2001
Limbic encephalitis not associated with neoplasm as a cause of temporal lobe epilepsyC G Bien, A Schulze-Bonhage, M Deckert, et al.
British Journal of Cancer|March 20, 2003
A33scFv-cytosine deaminase: a recombinant protein construct for antibody-directed enzyme-prodrug therapyP M Deckert, C Renner, L S Cohen, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|January 1, 1993
Expansion of peripheral blood natural killer cells correlates with clinical outcome in cancer patients receiving recombinant subcutaneous interleukin-2 and interferon-alpha-2J Atzpodien, H Kirchner, A Körfer, et al.
Seminars in Oncology|December 1, 1993
European studies of interleukin-2 in metastatic renal cell carcinomaJ Atzpodien, H Kirchner, E L Hänninen, et al.
Oncology|July 1, 1994
Immunocytochemical detection of P-glycoprotein: initial expression correlates with survival in renal cell carcinoma patientsS Duensing, I Dallmann, J Grosse, et al.
Journal of Receptor and Signal Transduction Research|January 15, 2005
From transcription profile to expression: the signaling repertoire of the SK-N-MC neuroepithelioma cell-lineJürgen E Bader, Cornelia M Deckert, Norman Koglin, et al.
Oncogene|April 4, 2007
Id3 is a novel regulator of p27kip1 mRNA in early G1 phase and is required for cell-cycle progressionA-A Chassot, L Turchi, T Virolle, et al.
Cancer Biotherapy|January 1, 1994
In vivo time and dose dependency of interleukin-6 secretion in response to low-dose subcutaneous recombinant interleukin-2M Meffert, E L Hanninen, T Menzel, et al.
The American Journal of Pathology|December 14, 1999
Primary central nervous system lymphomas are derived from germinal-center B cells and show a preferential usage of the V4-34 gene segmentM Montesinos-Rongen, R Küppers, D Schlüter, et al.
Neuropathology and Applied Neurobiology|March 5, 2013
Differential effects of CXCR4-CXCL12- and CXCR7-CXCL12-mediated immune reactions on murine P0106-125 -induced experimental autoimmune neuritisA Brunn, O Utermöhlen, M Mihelcic, et al.
Pageof 15